Overview

Investigating the Safety Profile of Liraglutide Under Normal Conditions of Use in Korean Subjects With Type 2 Diabetes Mellitus

Status:
Completed
Trial end date:
2017-03-08
Target enrollment:
Participant gender:
Summary
This trial is conducted in Asia. The aim of this study is to investigate the safety profile of liraglutide (Victoza®) under normal conditions of use in Korean subjects with type 2 diabetes mellitus.
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Liraglutide